Skip to main content
eScholarship
Open Access Publications from the University of California

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

  • Author(s): Long, SA
  • Rieck, M
  • Sanda, S
  • Bollyky, JB
  • Samuels, PL
  • Goland, R
  • Ahmann, A
  • Rabinovitch, A
  • Aggarwal, S
  • Phippard, D
  • Turka, LA
  • Ehlers, MR
  • Bianchine, PJ
  • Boyle, KD
  • Adah, SA
  • Bluestone, JA
  • Buckner, JH
  • Greenbaum, CJ
  • et al.
Main Content
Current View